Hyewon Ryu

发表

Liposomal irinotecan plus fluorouracil and leucovorin versus fluorouracil and leucovorin for metastatic biliary tract cancer after progression on gemcitabine plus cisplatin (NIFTY): a multicentre, open-label, randomised, phase 2b study.

G. Abou-Alfa, J. Cheon, J. S. Lee, 2021, The Lancet. Oncology.

A phase II study of chemotherapy in combination with telomerase peptide vaccine (GV1001) as second-line treatment in patients with metastatic colorectal cancer

I. Hwang, B. Han, J. H. Kim, 2022, Journal of Cancer.

Impact of family caregivers’ awareness of the prognosis on their quality of life/depression and those of patients with advanced cancer: a prospective cohort study

K. Jung, Y. Yun, Eunkyo Kang, 2020, Supportive Care in Cancer.

Development and validation of the quality care questionnaire –palliative care (QCQ-PC): patient-reported assessment of quality of palliative care

Y. Yun, Eunkyo Kang, J. Sim, 2018, BMC Palliative Care.

The Situation of Life-Sustaining Treatment One Year after Enforcement of the Act on Decisions on Life-Sustaining Treatment for Patients at the End-of-Life in Korea: Data of National Agency for Management of Life-Sustaining Treatment

Ha Yeon Lee, H. Kim, Y. Won, 2021, Cancer research and treatment.

Current Status and Cardinal Features of Patient Autonomy after Enactment of the Life-Sustaining Treatment Decisions Act in Korea

Ha Yeon Lee, H. Kim, Y. Won, 2021, Cancer research and treatment.

ATG9B Is a Poor Prognostic Marker Associated With Immune Evasion in Colon Adenocarcinoma

Sang Yeon Cho, Kyung Yol Lee, Miso Yang, 2023, AntiCancer Research.

A Phase II Study to Compare the Safety and Efficacy of Direct Oral Anticoagulants versus Subcutaneous Dalteparin for Cancer-Associated Venous Thromboembolism in Patients with Advanced Upper Gastrointestinal, Hepatobiliary and Pancreatic Cancer: PRIORITY

Keun-Wook Lee, J. Cheon, S. Seo, 2022, Cancers.

Life-Sustaining Treatment States in Korean Cancer Patients after Enforcement of Act on Decisions on Life-Sustaining Treatment for Patients at the End of Life

Ha Yeon Lee, H. Kim, Y. Won, 2021, Cancer research and treatment.

Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial

Joon-Oh Park, H. Harputluoglu, G. Brandi, 2023, The Lancet.

Attitudes of the General Public, Cancer Patients, Family Caregivers, and Physicians Toward Advance Care Planning: A Nationwide Survey Before the Enforcement of the Life-Sustaining Treatment Decision-Making Act.

K. Jung, Y. Yun, J. Sim, 2019, Journal of pain and symptom management.

Treatment With Liposomal Irinotecan Plus Fluorouracil and Leucovorin for Patients With Previously Treated Metastatic Biliary Tract Cancer: The Phase 2b NIFTY Randomized Clinical Trial.

G. Abou-Alfa, J. Cheon, B. Ryoo, 2023, JAMA oncology.

Preparation and Practice of the Necessary Documents in Hospital for the “Act on Decision of Life-Sustaining Treatment for Patients at the End-of-Life”

H. Kim, Y. Won, S. K. Baek, 2021, Cancer research and treatment.